ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 42 filers reported holding ONCOMED PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $60,000 | +36.4% | 58,048 | 0.0% | 0.00% | – |
| Q4 2018 | $44,000 | -65.1% | 58,048 | -2.4% | 0.00% | – |
| Q3 2018 | $126,000 | -8.0% | 59,448 | -0.0% | 0.00% | – |
| Q2 2018 | $137,000 | -27.1% | 59,467 | +0.8% | 0.00% | – |
| Q1 2018 | $188,000 | -22.3% | 59,010 | -0.0% | 0.00% | – |
| Q4 2017 | $242,000 | -18.5% | 59,017 | -10.3% | 0.00% | – |
| Q3 2017 | $297,000 | +16.5% | 65,799 | -13.8% | 0.00% | – |
| Q2 2017 | $255,000 | -89.8% | 76,373 | -71.9% | 0.00% | -100.0% |
| Q1 2017 | $2,499,000 | +10.8% | 271,350 | -7.2% | 0.00% | 0.0% |
| Q4 2016 | $2,255,000 | -23.2% | 292,494 | +13.8% | 0.00% | 0.0% |
| Q3 2016 | $2,937,000 | +6.8% | 256,933 | +15.0% | 0.00% | 0.0% |
| Q2 2016 | $2,749,000 | +34.0% | 223,346 | +10.1% | 0.00% | 0.0% |
| Q1 2016 | $2,051,000 | -54.5% | 202,907 | +1.5% | 0.00% | 0.0% |
| Q4 2015 | $4,505,000 | +42.4% | 199,874 | +4.8% | 0.00% | 0.0% |
| Q3 2015 | $3,163,000 | -5.3% | 190,664 | +28.4% | 0.00% | 0.0% |
| Q2 2015 | $3,340,000 | -3.4% | 148,445 | +10.7% | 0.00% | 0.0% |
| Q1 2015 | $3,458,000 | +23.9% | 134,148 | +4.6% | 0.00% | 0.0% |
| Q4 2014 | $2,791,000 | +9.8% | 128,251 | -4.5% | 0.00% | 0.0% |
| Q3 2014 | $2,542,000 | +70.1% | 134,311 | +109.5% | 0.00% | – |
| Q2 2014 | $1,494,000 | -23.7% | 64,111 | +10.2% | 0.00% | -100.0% |
| Q1 2014 | $1,958,000 | +3.7% | 58,189 | -9.0% | 0.00% | 0.0% |
| Q4 2013 | $1,888,000 | +427.4% | 63,976 | +173.8% | 0.00% | – |
| Q3 2013 | $358,000 | – | 23,366 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,108,815 | $4,273,000 | 0.48% |
| Birchview Capital, LP | 372,557 | $387,000 | 0.24% |
| Perceptive Advisors | 1,719,111 | $1,787,000 | 0.05% |
| Fondren Management LP | 25,136 | $26,000 | 0.02% |
| Cannell & Co. | 281,983 | $293,000 | 0.01% |
| APPLETON PARTNERS INC/MA | 66,206 | $69,000 | 0.01% |
| Quinn Opportunity Partners LLC | 66,162 | $69,000 | 0.01% |
| NJ State Employees Deferred Compensation Plan | 38,000 | $40,000 | 0.01% |
| Candriam S.C.A. | 380,000 | $395,000 | 0.01% |
| PRIMECAP MANAGEMENT CO/CA/ | 5,451,400 | $5,669,000 | 0.00% |